Select Your Region

Hemos detectado que accedes a esta página desde United States Selecciona tu región preferida para continuar.

Ir a United States (English)
ir al contenido

Selector de país

Según su ubicación

Europe

North America

Latin America

Asia-Pacific

Verificación del sector sanitario

Esta sección contiene información destinada a los profesionales sanitarios.

Confirme que pertenece a una empresa del sector sanitario.

Results from a Pilot Study in the Portuguese Population on Newborn Screening for Sickle Cell Disease

The DBS samples were analyzed by Capillary Electrophoresis using two generations of instruments from the Sebia Capillarys range of automated systems.

Publicado: 12/11/2026 | Modificado: 12/11/2026

The Portuguese Newborn Screening Program currently includes 28 conditions: Congenital Hypothyroidism, Cystic Fibrosis, 24 inborn errors of metabolism, Sickle Cell Disease, and Spinal Muscular Atrophy.

This pilot study on newborn screening for Sickle Cell Disease was conducted between May 2021 and December 2023 and involved more than 188,000 samples. Dried Blood Spots (DBS) samples were analyzed via Capillary Electrophoresis using the Sebia CAPILLARYS 2 Neonat Fast system during Phase I and the CAPILLARYS 3 DBS system during Phase II.

The results revealed an incidence of 1 case per 2,449 births, suggesting that this condition is of growing importance in Portugal, thus reflecting a general European trend, in which Sickle Cell Disease is already recognized as a public health issue.

Test associated with this resource

Related instrument

Discover more resources on Hemoglobin Disorders

Esta sección contiene información destinada a una amplia difusión y, por lo tanto, puede incluir detalles de productos o información que no esté disponible o no sea válida en su país. Póngase en contacto con su representante local de Sebia. Información destinada a profesionales sanitarios. Lea atentamente las instrucciones que figuran en los prospectos de los reactivos y en los manuales de los instrumentos.